San Diego, Calif.-based Torrey Pines Investment (TPI), a specialty life-science investor, and BioMotiv, an accelerator company associated with The Harrington Project for Discovery & Development, have signed a joint investment framework to fund early stage life-science programs and companies over the next seven years. 

The agreement will fund innovative ideas emerging from research institutions with a focus on creating new medicines by quickly and cost-effectively moving platforms, compounds and candidates from early-stage development through clinical proof-of-concept. Investments are planned across multiple therapeutic areas and disease targets. The technologies can come from any location worldwide, enabling both organizations to tap into their regional and global R&D networks.